文献速递产科母胎医学

胎盘植入谱系保守治疗后的再次妊娠结局及危险因素:一项回顾性队列研究

Subsequent pregnancy outcomes and risk factors following conservative treatment for placenta accreta spectrum: a retrospective cohort study.
PubMed 文献 · Am J Obstet Gynecol MFM · 2023-10-12

该回顾性队列研究纳入2011至2019年郑州大学第一附属医院883例接受保守手术的胎盘植入谱系患者,604例成功随访,其中72例共75次妊娠,22例足月或近足月分娩的新生儿均存活,复发胎盘植入谱系5例(22.7%),剖宫产瘢痕妊娠6例(8.0%),产后出血2例(9.1%)。年龄、孕次、剖宫产次数、既往胎盘植入谱系类型、终止妊娠孕周、妊娠间隔及血管阻断技术使用均与复发胎盘植入谱系及剖宫产瘢痕妊娠无关。

要点

  • 保守手术治疗的胎盘植入谱系患者中,72例共75次再次妊娠,22例足月或近足月分娩新生儿均存活。
  • 再次妊娠中复发胎盘植入谱系5例(22.7%),剖宫产瘢痕妊娠6例(8.0%),产后出血2例(9.1%)。
  • 年龄、孕次、剖宫产次数、既往类型、终止孕周、妊娠间隔及血管阻断技术使用与复发无关。

核心结论

  • 胎盘植入谱系的保守治疗并不自动排除再次妊娠的可能,但应充分告知患者复发胎盘植入谱系、瘢痕妊娠及产后出血的风险。

研究设计与样本

  • 回顾性队列研究,纳入2011至2019年郑州大学第一附属医院剖宫产时接受胎盘植入谱系保守手术并后续妊娠的病例。
  • 共883例接受保守手术,604例(68.4%)成功随访,72例患者共75次成功妊娠。

主要发现

  • 75次妊娠中包括22例足月或近足月分娩、1例孕中期引产、6例剖宫产瘢痕妊娠(8.0%)、2例异位妊娠、44例早孕期妊娠(3例流产、41例择期流产、12例药物流产及32例负压吸引术)。
  • 22例足月或近足月分娩的新生儿均存活;观察到胎盘植入谱系5例(22.7%)及前置胎盘6例。
  • 产后出血2例,发生率9.1%。
  • 再次妊娠时年龄、孕次、剖宫产次数、既往胎盘植入谱系类型、终止妊娠孕周、妊娠间隔及血管阻断技术使用均与复发胎盘植入谱系及剖宫产瘢痕妊娠无关。

临床怎么用

  • 作者认为保守治疗胎盘植入谱系后仍可能再次妊娠,但应充分告知患者复发胎盘植入谱系、瘢痕妊娠及产后出血的风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Placenta accreta spectrum can lead to uncontrollable massive hemorrhage in the perinatal period. Currently, the first-line treatment for placenta accreta spectrum recommended worldwide is hysterectomy. However, adverse outcomes after hysterectomy, including surgical complications, such as difficulty in performing the procedure, and sequelae, such as infertility and psychological issues, cannot be ignored. Several surgical approaches for conservative treatment have been proposed. There are few reports on the effectiveness, safety, and long-term complications of conservative treatments, especially subsequent pregnancy outcomes. OBJECTIVE: This study aimed to investigate the clinical outcomes and identify risk factors of subsequent pregnancies among patients with placenta accreta spectrum who had undergone conservative surgery. STUDY DESIGN: This was a retrospective cohort study of subsequent pregnancy cases after cesarean delivery with conservative treatment for placenta accreta spectrum from 2011 to 2019 at The First Affiliated Hospital of Zhengzhou University to identify clinical outcomes of subsequent pregnancies and the risk factors of adverse pregnancy outcomes. RESULTS: A total of 883 patients undergoing conservative surgery were included in this study, among which 604 (68.4%) were successfully followed up. There were 75 successful pregnancies in 72 patients, including 22 full-term or near-term deliveries, 1 induced labor in the second trimester of pregnancy, 6 cesarean scar pregnancies (8.0%), 2 ectopic pregnancies, and 44 first-trimester pregnancies (3 miscarriages and 41 elective abortions and 12 medical abortions and 32 vacuum aspirations). All newborns survived in the 22 full-term or near-term deliveries. Moreover, 5 placenta accreta spectrum cases (22.7%) and 6 placenta previa cases were observed. Postpartum hemorrhage was observed in 2 cases, with an incidence rate of 9.1%. All parameters, including age at subsequent pregnancy, gravidity, number of cesarean deliveries, type of previous placenta accreta spectrum, gestational week of pregnancy termination, interpregnancy interval, and the use of vascular occlusion techniques, were not found to be associated with recurrent placenta accreta spectrum and cesarean scar pregnancy. CONCLUSION: Our findings show that treatment for placenta accreta spectrum does not automatically preclude a subsequent pregnancy. However, patients should be fully informed about the risk of recurrent placenta accreta spectrum, scar pregnancy, and postpartum hemorrhage.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Zhao H, Liu C, Fu H, et al. Subsequent pregnancy outcomes and risk factors following conservative treatment for placenta accreta spectrum: a retrospective cohort study. Am J Obstet Gynecol MFM. 2023. PMID: 37832645. doi:10.1016/j.ajogmf.2023.101189

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。